300 related articles for article (PubMed ID: 26831511)
1. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.
Leehy KA; Regan Anderson TM; Daniel AR; Lange CA; Ostrander JH
J Mol Endocrinol; 2016 Apr; 56(3):R99-R114. PubMed ID: 26831511
[TBL] [Abstract][Full Text] [Related]
2. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor and breast cancer.
Vilasco M; Communal L; Mourra N; Courtin A; Forgez P; Gompel A
Breast Cancer Res Treat; 2011 Nov; 130(1):1-10. PubMed ID: 21818591
[TBL] [Abstract][Full Text] [Related]
4. Post-translational modifications of steroid receptors.
Faus H; Haendler B
Biomed Pharmacother; 2006 Nov; 60(9):520-8. PubMed ID: 16949786
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation.
Ward RD; Weigel NL
Biofactors; 2009; 35(6):528-36. PubMed ID: 19904813
[TBL] [Abstract][Full Text] [Related]
6. 90 YEARS OF PROGESTERONE: Steroid receptors as MAPK signaling sensors in breast cancer: let the fates decide.
Dwyer AR; Truong TH; Ostrander JH; Lange CA
J Mol Endocrinol; 2020 Jul; 65(1):T35-T48. PubMed ID: 32209723
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modifications of the progesterone receptors.
Abdel-Hafiz HA; Horwitz KB
J Steroid Biochem Mol Biol; 2014 Mar; 140():80-9. PubMed ID: 24333793
[TBL] [Abstract][Full Text] [Related]
8. Hormone receptors in breast cancer: more than estrogen receptors.
Lamb CA; Vanzulli SI; Lanari C
Medicina (B Aires); 2019; 79(Spec 6/1):540-545. PubMed ID: 31864223
[TBL] [Abstract][Full Text] [Related]
9. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.
Smith RA; Lea RA; Weinstein SR; Griffiths LR
Cancer Lett; 2007 Sep; 255(1):77-84. PubMed ID: 17512111
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptors in breast cancer.
Beck CA; Edwards DP
Cancer Treat Res; 1992; 61():317-52. PubMed ID: 1360240
[No Abstract] [Full Text] [Related]
11. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
Daniel AR; Faivre EJ; Lange CA
Mol Endocrinol; 2007 Dec; 21(12):2890-906. PubMed ID: 17717077
[TBL] [Abstract][Full Text] [Related]
12. Tracking progesterone receptor-mediated actions in breast cancer.
Knutson TP; Lange CA
Pharmacol Ther; 2014 Apr; 142(1):114-25. PubMed ID: 24291072
[TBL] [Abstract][Full Text] [Related]
13. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract][Full Text] [Related]
14. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells.
Richer JK; Jacobsen BM; Manning NG; Abel MG; Wolf DM; Horwitz KB
J Biol Chem; 2002 Feb; 277(7):5209-18. PubMed ID: 11717311
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
[TBL] [Abstract][Full Text] [Related]
16. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
[TBL] [Abstract][Full Text] [Related]
17. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.
Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A
Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
19. Dynamic regulation of steroid hormone receptor transcriptional activity by reversible SUMOylation.
Knutson TP; Lange CA
Vitam Horm; 2013; 93():227-61. PubMed ID: 23810010
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing and the progesterone receptor in breast cancer.
Cork DM; Lennard TW; Tyson-Capper AJ
Breast Cancer Res; 2008; 10(3):207. PubMed ID: 18557990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
